Guangyu Jiao1, Erran Li, Runjiang Yu. 1. Institute of Respiratory Disease, The First Clinical Hospital, China Medical University, Shenyang 110001, China. guangyujiao@263.net
Abstract
OBJECTIVE: To determine if aquaporin1 (AQP1) and aquaporin5 (AQP5) are expressed in the alveolar capillary membrane in rats. Moreover, to investigate the alteration of AQP1 and AQP5 in acute injured lungs. METHODS: The distribution of AQP1 and AQP5 in alveolar capillary membrane were investigated by immunohistochemistry and immunoelectron microscopy with affinity-purified antibodies to human AQP1 and AQP5. To study the possibility that alveolar capillary membrane AQP1 and AQP5 undergo altered regulation, we established a rat model using alveolar instillation of lipopolysaccharide (LPS). RESULTS: Immunolabelling showed AQP1 was stained primarily in the microvascular endotheli a of normal lungs, while AQP5 was expressed in type I pneumocytes. Immunohisto chemical analysis showed a significant decrease in the expression of AQP1 and AQP5 in injured lungs at 4h-48h after LPS instillation. AQP1 protein was resumed partly at 24h after LPS instillation and steroid administration, whereas AQP5 was unchanged. CONCLUSION: The decreased expressions of AQP1 and AQP5 in injured lungs suggest that both of them may play a role in abnormal fluid transportation.
OBJECTIVE: To determine if aquaporin1 (AQP1) and aquaporin5 (AQP5) are expressed in the alveolar capillary membrane in rats. Moreover, to investigate the alteration of AQP1 and AQP5 in acute injured lungs. METHODS: The distribution of AQP1 and AQP5 in alveolar capillary membrane were investigated by immunohistochemistry and immunoelectron microscopy with affinity-purified antibodies to humanAQP1 and AQP5. To study the possibility that alveolar capillary membrane AQP1 and AQP5 undergo altered regulation, we established a rat model using alveolar instillation of lipopolysaccharide (LPS). RESULTS: Immunolabelling showed AQP1 was stained primarily in the microvascular endotheli a of normal lungs, while AQP5 was expressed in type I pneumocytes. Immunohisto chemical analysis showed a significant decrease in the expression of AQP1 and AQP5 in injured lungs at 4h-48h after LPS instillation. AQP1 protein was resumed partly at 24h after LPS instillation and steroid administration, whereas AQP5 was unchanged. CONCLUSION: The decreased expressions of AQP1 and AQP5 in injured lungs suggest that both of them may play a role in abnormal fluid transportation.
Authors: H Liu; S B Hooper; A Armugam; N Dawson; T Ferraro; K Jeyaseelan; A Thiel; I Koukoulas; E M Wintour Journal: J Physiol Date: 2003-06-20 Impact factor: 5.182
Authors: Alice G Vassiliou; Nikolaos Manitsopoulos; Matina Kardara; Nikolaos A Maniatis; Stylianos E Orfanos; Anastasia Kotanidou Journal: In Vivo Date: 2017 Sep-Oct Impact factor: 2.155
Authors: Venkataramana K Sidhaye; Eric Chau; Vasudha Srivastava; Srinivas Sirimalle; Chinmayee Balabhadrapatruni; Neil R Aggarwal; Franco R D'Alessio; Douglas N Robinson; Landon S King Journal: PLoS One Date: 2012-06-08 Impact factor: 3.240
Authors: Gustavo Fabregat; José García-de-la-Asunción; Benjamín Sarriá; Julio Cortijo; José De Andrés; Manuel Mata; Ernesto Pastor; Francisco Javier Belda Journal: PLoS One Date: 2014-12-09 Impact factor: 3.240